Bellingan, G., Brealey, D., Mancebo Cortes, J., Mercat, A., Patroniti, N., Pettilä, V., . . . Ranieri, V. (2017). Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome.
Citación estilo ChicagoBellingan, Geoff, et al. Comparison of the Efficacy and Safety of FP-1201-lyo (intravenously Administered Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients With Moderate or Severe Acute Respiratory Distress Syndrome. 2017.
Cita MLABellingan, Geoff, et al. Comparison of the Efficacy and Safety of FP-1201-lyo (intravenously Administered Recombinant Human Interferon Beta-1a) and Placebo in the Treatment of Patients With Moderate or Severe Acute Respiratory Distress Syndrome. 2017.